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Infectious bursal disease virus (IBDV) encodes a 17-kDa nonstructural polypeptide known as VP5. This polypeptide is not
essential for virus replication in vitro but it plays an important role in in vivo dissemination and pathogenesis. We have
characterized the expression of VP5 in three eukaryotic systems: (i) IBDV-infected chicken embryo fibroblasts; (ii) BSC-1 cells
infected with a recombinant vaccinia virus vector; and (iii) Cos-1 cells transiently transfected with a plasmid vector.
Immunofluorescence analyses showed that upon expression VP5 accumulates within the plasma membrane. This finding
was consistent with sequence-based topology predictions, indicating that VP5 is a class II membrane protein with a
cytoplasmic N-terminus and an extracellular C-terminal domain. Brefeldin A treatment of VP5-expressing cells prevented the
accumulation of this polypeptide in the plasma membrane, thus showing the requirement of an active exocytic pathway to
reach that compartment. Expression of VP5 was shown to be highly cytotoxic. Induction of VP5 expression resulted in the
alteration of cell morphology, the disruption of the plasma membrane, and a drastic reduction of cell viability. VP5-induced
cytotoxicity was prevented by blocking its transport to the membrane with Brefeldin A. Our findings suggest that VP5 plays
an important role in the release of the IBDV progeny. © 2000 Academic Press
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aINTRODUCTION
Infectious bursal disease virus (IBDV), a member of
the Birnaviridae family, infects young chickens causing a
isease (IBD) characterized by the destruction of B-lym-
hocyte precursors found within the bursa of Fabricius.
his causes a severe immunodeficiency that increases
he susceptibility to infections with opportunistic patho-
ens and reduces the growth rate of surviving animals.
BDV is one of the most important pathogens affecting
he poultry industry worldwide (Mu¨ller et al., 1992; Na-
arajan and Kibenge, 1995; Saif, 1998).
IBDV consists of a nonenveloped capsid of 60 nm
Bo¨tcher et al., 1997; Hirai and Shimakura, 1974; O¨zel and
elderblom, 1985) that contains two segments of double-
tranded RNA (dsRNA) of 3.2 kb (segment A) and 2.8 kb
segment B) (Hudson et al., 1986). Segment B contains
ne open reading frame (ORF) that encodes VP1, a pro-
ein of 97 kDa considered to be an RNA-dependent RNA
olymerase (RdRp) responsible for the replication and
ranscription of the viral genome (Macreadie and Azad,
993). Segment A contains two partially overlapping
RFs. The largest one encodes a 109-kDa polyprotein
hat is proteolytically cleaved, rendering three polypep-
ides: VPX, VP3, and VP4 (Dobos et al., 1995). VPX is
urther processed into VP2 (Mu¨ller and Becht, 1982). VPX,p1 To whom correspondence and reprint requests should be ad-
ressed. Fax: 34-91-5854506. E-mail: jfrodrig@cnb.uam.es.
345P2, and VP3 are structural proteins forming the virus
apsid and VP4 is responsible for the processing of the
olyprotein (Fahey et al., 1985; Hudson et al., 1986;
ibenge et al., 1997). The smallest ORF encodes VP5,
lso known as NS, a nonstructural protein of 17 kDa,
ighly basic, cysteine-rich, and conserved among all
athogenic strains of IBDV. It has been shown that VP5 is
xpressed in IBDV-infected cells but it is not incorpo-
ated into the virion (Mundt et al., 1995).
The use of a reverse genetics system allowed the
eneration of a VP5 knockout mutant. Work with the
P52 mutant has shown that VP5 is dispensable for virus
replication in vitro (Mundt et al., 1997). Interestingly, this
utant showed a highly attenuated phenotype and did
ot cause bursal lesions after experimental infection of
usceptible chickens, demonstrating that VP5 plays a
ey role in IBDV pathogenesis and dissemination (Yao et
l., 1998). Consequently, VP5 has attracted attention as a
otential target for the development of strategies to con-
rol IBDV.
Despite strong interest in VP5, very little was known
bout it. We have sought to gather new information that
ight provide clues about the functional role of this
rotein and its contribution to the virus life cycle. The
irnavirus life cycle has not been characterized in detail.
ence key steps such as entry, genome transcription
nd replication, morphogenesis, and release of the viral
rogeny are poorly understood.
Birnaviruses are cytolytic viruses, but the molecular
0042-6822/00 $35.00
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346 LOMBARDO ET AL.mechanism(s) employed for virus egress is, as yet, un-
known. Most of the knowledge on virus release mecha-
nisms derives from studies on enveloped viruses that
bud from the plasma membrane (Garoff et al., 1998). In
ontrast, nonenveloped viruses have long been thought
o be released following cell lysis. It is thought that either
he viral gene expression or the formation and accumu-
ation of virus particles induce changes in membrane
ermeability, eventually leading to cell lysis. However,
ata from different virus–cell systems suggest that ex-
ression of a single viral protein may be responsible for
ell lysis (Carrasco, 1995). Several such proteins have
een identified, i.e., the 2B proteins of poliovirus and
oxsackievirus, the rotavirus NSP4, and the adenovirus
3-11.6K. Death proteins have been implicated in the
lteration and eventual disruption of the host cell plasma
embrane permeability (Aldabe et al., 1996; Newton et
l., 1997; Tollefson et al., 1996; Van Kuppeveld et al.,
997).
Here we describe the characterization of the expres-
FIG. 1. (A) VP5 deduced amino acid sequence. The sequence corres
helix is indicated by a black box and white lettering. The VP5 C-terminal
in this report is boxed. (B) Hydropathy plot of the VP5 polypeptide. The p
the results obtained with the highly favored predicted orientation corre
dashed line represents hydropathy values for the opposite orientationion of VP5 in several cell systems. Topological predic-
ions indicating that VP5 is a class II transmembrane
t
protein were confirmed by the results of immunofluores-
ence (IF) analyses. Expression of VP5 in different cell
ystems caused severe cytotoxic effects characterized
y extensive alterations in cell morphology, the disrup-
ion of the plasma membrane, and the eventual induction
f cell lysis. Based on the results of this study and
revious reports, we propose that VP5 acts as a death
rotein, modifying the cell membrane and promoting the
gress of the newly formed IBDV virions.
RESULTS
P5 topology
As shown in Fig. 1A, VP5 is formed by 145 amino acid
esidues and has a predicted molecular mass of 16.7
Da. Analyses of the secondary structure of VP5 using
he TMpred and TopPred programs showed the pres-
nce of a putative transmembrane hydrophobic helix
ithin the central region of the polypeptide (aa 69 to 88)
Fig. 1A). According to these results, VP5 would belong to
o the IBDV Soroa strain. The position of the predicted transmembrane
corresponding to the oligopeptide used to raise the anti-VP5 sera used
generated using the TMpred program. The continuous line represents
ng to a transmembrane protein with a C-terminal cytoplasmic tail. The
ted hydrophobic regions are above the axis.ponds t
region
lot washe class II transmembrane protein group. VP5 would
ossess an N-terminal cytoplasmic tail and a C-terminal
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347EXPRESSION OF INFECTIOUS BURSAL DISEASE VIRUS VP5 INDUCES CELL LYSISextracellular domain. Extensive searches of protein data
banks did not detect significant homologies to known
polypeptides other than VP5 counterparts from different
Birnaviruses.
VP5 expression in IBDV-infected cells
As a first step in our analysis we characterized the
expression of VP5 during the virus life cycle. For this,
IBDV-infected chicken embryo fibroblasts (CEF) were
analyzed by IF using antisera against the five virus-
encoded mature polypeptides including VP5. The anti-
VP5 antiserum used in this report was raised against a
16-amino-acid-long synthetic oligopeptide containing the
VP5 C-terminus (see Fig. 1A). As shown in Fig. 2, the
structural polypeptides VP1, VPX/2, and VP3 are associ-
ated with large viroplasm-like aggregates within the cell
cytoplasm. The VP4 antiserum yielded a characteristic
needle-like signal, most likely corresponding to the de-
scribed IBDV type II tubules (Granzow et al., 1997). Pre-
mmune sera, used as control for these experiments,
ave dull negative signals (data not shown). Noteworthy,
he anti-VP5 antiserum gave a distinctive plasma mem-
rane staining. This result was in agreement with topol-
gy predictions indicating that VP5 is a transmembrane
olypeptide.
xpression of recombinant VP5 in mammalian cells
To carry out a systematic characterization of VP5 it
as important to develop vectors to achieve the expres-
ion of this polypeptide in different cell systems. A cDNA
orresponding to the VP5 coding region was obtained
nd cloned into the VV transfer inducible vector pVOTE.2
Ward et al., 1995) (see Materials and Methods). The
resulting plasmid, pVOTE/VP5, was utilized to generate
FIG. 2. Subcellular distribution of virus-encoded polypeptides in IBD
were fixed and incubated with rabbit anti-VP1, -VP2/X, -VP3, -VP4, or
Samples were viewed by epifluorescence.recombinant VV (rVV) VT7/VP5, which was then used to
follow the expression of VP5 in mammalian cells.Monolayers of BSC-1 cells were infected with VT7/
VP5. After infection, cells were supplemented or not with
the specific inducer isopropyl b-D-thiogalactoside (IPTG).
At 10 h postinfection (p.i.) cells were harvested and
analyzed by SDS–PAGE and autoradiography. As ex-
pected, addition of IPTG specifically triggered the ex-
pression of a 17-kDa polypeptide that was recognized by
the VP5-specific antiserum (Figs. 3A and 3B, lanes 4).
The electrophoretic mobility of the IPTG-induced product
was similar to that of the original VP5 expressed in baby
Grivet monkey kidney (BGM70) cells infected with IBDV
(Figs. 3A and 3B, lane 6). Interestingly, in cells infected
with VT7/VP5, a reduction in the total protein synthesis
was consistently observed after induction of VP5 expres-
sion (Fig. 3B, lanes 3 and 4), indicating that VP5 might
possess cytotoxic properties.
Interestingly, when the samples were subjected to
nonreducing SDS–PAGE, the VP5-specific band was no
longer detectable. A Western blot analysis of the corre-
sponding gels showed the presence of several VP5-
specific faint bands of over 200 kDa as well as a diffuse
accumulation within the upper edge of the gel (data not
shown). The dramatic reduction of the VP5-specific sig-
nal detected in Western blots performed after nonreduc-
ing SDS–PAGE might also be due to the masking of the
epitope(s) recognized by the anti-peptide VP5 serum. It
has been recently described that VP5 is able to self-
aggregate (Tacken et al., 2000). Therefore, it seems likely
that the high-molecular-weight anti-VP5 reactive bands
correspond to VP5 aggregates.
VT7/VP5-infected BSC-1 cells were videorecorded by
time-lapse phase-contrast microscopy. A set of selected
images is shown in Fig. 3C. Uninduced VT7/VP5-infected
cells showed cytopathic effects characteristic of hemag-
ted CEF. Cells were infected at an m.o.i. of 5 PFU/cell and at 18 h p.i.
ra followed by incubation with FITC-conjugated goat anti-rabbit IgG.V-infecglutinin negative VV, i.e., cell rounding and fusion (Seki et
al., 1990). Insertion of the heterologous genes into the
348 LOMBARDO ET AL.
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349EXPRESSION OF INFECTIOUS BURSAL DISEASE VIRUS VP5 INDUCES CELL LYSISgenome of VV using pVOTE vectors leads to the disrup-
tion of the hemagglutinin gene (Ward et al., 1995). In
ontrast, VP5-expressing cells underwent dramatic alter-
tions. In addition to the rounding, VP5-expressing cells
howed a high motility and membrane blebbing. Be-
ween 8 and 12 h p.i. IPTG-induced cells became pro-
ressively flatter and their movement slower. At 16 h p.i.
ells were completely spread out and motionless (Fig. 3).
inally, at 16 h p.i. cells began detaching from the culture
urface.
ubcellular distribution of VP5
BSC-1 cells were infected with VT7/VP5 and analyzed
y IF using the anti-VP5 rabbit antiserum followed by
ncubation with FITC-conjugated goat anti-rabbit Ig. The
amples were also stained with Texas red-conjugated
TXRD) wheat germ agglutinin (WGA) to determine the
osition of the plasma membrane and Golgi complex
Tartakoff and Vassalli, 1983). In TX-100 permeabilized
ells, VP5 was detected as a large spot within the pe-
inuclear region (Fig. 4A, panel viii), suggesting the pres-
nce of this polypeptide within the Golgi system. This
as confirmed by the matching WGA signal (Fig. 4A,
anel vii).
In nonpermeabilized IPTG-induced VT7/VP5-infected
ells, both the anti-VP5 antiserum and the TXRD-WGA
onjugate specifically stained the cell surface (Fig. 4A,
anels v and vi). The membrane of IPTG-induced cells
as shown to contain abundant VP5-specific fluorescent
ing-like patches, suggesting the presence of large VP5
ggregates within this compartment (Fig. 4A, panel vi).
nexpectedly, incubation of nonpermeabilized VP5-ex-
ressing cells with either WGA or anti-VP5 antiserum
ave a weak Golgi complex staining (Fig. 4A, panels v
nd vi). This finding suggested that VP5 might alter the
ell membrane, thus allowing the access of macromol-
cules to the cell cytoplasm.
The subcellular distribution of VP5 was also analyzed
n Cos-1 cells transfected with the plasmid expression
ector pcINeo/VP5. Similarly to what had been observed
n IBDV- and VT7/VP5-infected cells, in transfected Cos-1
ells the VP5 signal was associated with both the
lasma membrane and the Golgi system (Fig. 4B, panels
i and iv).
FIG. 3. Characterization of the VP5 expression in cells infected with
VT7LacOI, either treated (1) or untreated (2) with the inducer IPTG an
labeled with [35S]methionine. Protein samples from the different cu
electroblotted onto nitrocellulose and subjected to autoradiography.
recombinant VV VT7/VP5. To determine the position of the VP5 polypep
anti-VP5 antisera and then with horseradish peroxidase-conjugated
naphthol. The positions of molecular mass markers are indicated (MW
changes induced by VP5 expression were followed by phase-contrast
presence or in the absence of IPTG. A series of micrographs corresponding
corresponding to IPTG-induced cells indicates the relative position of same sTaken together these results demonstrate that, re-
gardless of the expression system used for the anal-
ysis, VP5 is found within the plasma membrane and
the Golgi system. The anti-VP5 serum used for this
work was raised against a synthetic peptide contain-
ing the sequence corresponding to the 16 aa from the
C-terminal VP5 region (see Fig. 1A). The strong reac-
tivity detected with this antiserum in nonpermeabilized
VP5-expressing cells strongly supports the prediction
that the C-terminal region of VP5 is exposed on the
external cell surface.
VP5 transport to the plasma membrane is blocked by
Brefeldin A (BFA)
The results of the IF analysis described above dem-
onstrated that VP5 accumulates within the plasma mem-
brane and suggested that to reach this compartment it
might require the exocytic pathway. To assess this hy-
pothesis we studied the effect of the blockage of this
pathway on the subcellular distribution of VP5. BSC-1
cells were infected with VT7/VP5 and, after adsorption,
expression of VP5 was induced by adding IPTG to the
cell medium. Cultures were then maintained either in the
presence or the absence of BFA (5 mg/ml), an agent
nown to rapidly disassemble the Golgi complex (Mi-
umi et al., 1986). At 16 h p.i. cells were fixed and
analyzed by IF using anti-VP5 serum and TXRD-conju-
gated WGA.
The BFA treatment caused a strong reduction of mem-
brane-associated VP5 signal (Fig. 5, panels ii and iv),
indicating that the presence of BFA inhibits the transport
of VP5 to the cell membrane. A dramatic effect of BFA on
the subcellular distribution of VP5 was detected in
T-X100-permeabilized cells. The large perinuclear fluo-
rescent spots detected in untreated cells (Fig. 5, panel vi)
were no longer found after the BFA treatment; instead a
fine punctuated VP5 fluorescence was observed (Fig. 5,
panel viii). This pattern was consistent with the accumu-
lation of VP5 in vesicles from the cis/medial Golgi com-
partments. Similar results were obtained in pcINEO/VP5-
transfected Cos-1 cells (data not shown). These results
clearly show that VP5 transit to the plasma membrane is
dependent upon the presence of a functional Golgi com-
plex.
VT7/VP5. (A) BSC-1 cells infected with VT7/VP5 or the parental virus
70 cells either mock-infected or infected with IBDV were metabolically
were subjected to SDS–PAGE. After electrophoresis, the gel was
stern blot analysis of proteins expressed in cells infected with the
fter autoradiography, the nitrocellulose filter was incubated with rabbit
ti-rabbit Ig. The signal was detected by incubation with 1-chloro-4-
s corresponding to VP5 are indicated by triangles. (C) Morphological
copy. Cells were infected with VT7/VP5 and maintained either in thethe rVV
d BGM
ltures
(B) We
tide, a
goat an
). Band
microsto the same field were taken at the indicated times. The arrowhead
elected cell at different time points.
the pl
ells.
350 LOMBARDO ET AL.VP5 expression induces cell death
It was consistently noticed, in both VT7/VP5-infected
and pcINEO/VP5-transfected cells, that VP5 expression
caused a swift alteration in cell morphology. In addition
to this, we had observed that expression of VP5 caused
a reduction in the total protein synthesis (Fig. 3). These
data suggested that accumulation of VP5 is toxic to the
host cell.
To further assess this possibility a series of experi-
ments was carried out. First, we studied the effect of VP5
expression on cell viability using the trypan blue dye
exclusion method (see Materials and Methods). BSC-1
cell cultures were infected with VT7/VP5 and maintained
in medium supplemented with IPTG. The percentage of
viable cells in the different cultures was determined at
different times p.i. As controls, infections were carried
FIG. 4. Subcellular distribution of VP5 expressed in mammalian cel
either in the presence or in the absence of IPTG. At 16 h p.i. cells were
anti-VP5 followed by incubation with FITC-conjugated goat anti-rabbit I
were viewed by epifluorescence. (B) Cos-1 cells were transfected with
as described above. Arrows indicate the position of VP5-expressing cout with the parental virus VT7LacOI and with VT7/VP3,
a rVV expressing the IBDV VP3 protein (Ferna´ndez-Ariaset al., 1997). As shown in Fig. 6A, a rapid decrease in cell
viability was observed in IPTG-induced VT7/VP5-infected
cultures. In these cultures, at 12 h p.i. less than 20% of
the total cell population remained viable by this criterion.
In contrast, at the same time postinfection, IPTG-induced
control cultures maintained viability levels of over 70%.
The effect of VP5 on cell viability was also monitored
using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tet-
razolium bromide (MTT) assay. As shown in Fig. 6B, the
mitochondrial activity levels of VT7LacOI- and VT7/VP3-
infected cells were not strongly affected by the infection.
However, in VT7/VP5 cells a rapid decrease of MTT
activity was specifically observed.
The trypan-blue and MTT assays showed that expres-
sion of VP5 specifically reduced cell viability. To further
confirm these observations, a method to assess cell
SC-1 cells were infected with VT7/VP5 at 5 PFU/cell and maintained
permeabilized or not with Triton X-100, and immunostained with rabbit
eafter, samples were incubated with TXRD-conjugated WGA. Samples
asmid pcINEO/VP5. At 48 h p.i. cells were fixed and processed for IFls. (A) B
fixed,
g. Therdeath was used. BSC-1 cell cultures were infected with
VT7/VP5 and maintained either in the presence or in the
l
r
V
2
i
m
(
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351EXPRESSION OF INFECTIOUS BURSAL DISEASE VIRUS VP5 INDUCES CELL LYSISabsence of IPTG. At 18 h p.i., cultures were fixed and
subjected to a double fluorescence staining using the
cell death detection FITC-TUNEL reagent and anti-VP5
antiserum followed by incubation with TXRD-conjugated
anti-rabbit IgG antiserum. As shown in Fig. 6C, a large
proportion (over 80%) of the VP5-expressing cells were
positive for TUNEL staining. The rather low proportion
(less than 5%) of TUNEL-positive cells detected in unin-
duced VT7/VP5-infected cultures confirmed the specific-
ity of this assay.
A direct correlation between VP5 expression and the
induction of cell death was also documented in pcINEO/
VP5-transfected Cos-1 cells (data not shown).
Results obtained with three independent methods
demonstrated that expression of VP5 specifically in-
duces a cell death response in mammalian cells.
BFA blocks the induction of cell death in VP5-
expressing cells
We consistently observed that addition of BFA to the
medium resulted in a marked delay in the onset of
VP5-induced morphological changes. This suggested
that the VP5-mediated cytotoxicity might require the ac-
cumulation of the polypeptide in the cell membrane. To
analyze this possibility, IPTG-induced VT7/VP5-infected
cells were maintained either in the presence or in the
absence of BFA. At 18 h p.i., cells were fixed and stained
with anti-VP5 and visualized by fluorescence microscopy.
As shown in Fig. 7, approximately 85–90% of the un-
treated VP5-expressing cells were also positive for both
FIG. 5. Effect of the BFA treatment on the subcellular distribution o
supplemented with IPTG. Cells were treated or not with BFA. At 16 h p.
with rabbit anti-VP5 followed by incubation with FITC-conjugated goat a
Cells were viewed by epifluorescence.VP5 antisera and TUNEL staining (Fig. 7, panels i and ii).
In BFA-treated cultures the fraction of double-positive
S
mcells was less than 20% (Fig. 7, panels iii and iv). These
results showed that the VP5-induced cytotoxicity is effi-
ciently prevented by an agent that blocks the accumula-
tion of VP5 within the plasma membrane.
VP5 expression induces cell lysis
As described above, IF analyses indicated that expres-
sion of VP5 might alter the permeability of the plasma
membrane, allowing the access of macromolecules to
the cytoplasm of nonpermeabilized paraformaldehyde-
fixed cells. These findings suggested that VP5 might
induce gross changes in the cell membrane. Accord-
ingly, the possibility existed that the plasma membrane
of VP5-expressing cells might allow the release of cyto-
solic proteins to the extracellular medium.
To test this hypothesis, BSC-1 cells were metabolically
labeled with [35S]methionine. After labeling, cells were
infected with VT7LacOI, VT7/VP3, or VT7/VP5. The cul-
tures were then maintained in either normal or IPTG-
containing medium. The presence of radioactive proteins
in the extracellular medium was assessed at different
times postinfection. Samples collected from control cul-
tures did not contain significant levels of [35S]methionine-
abeled proteins (Fig. 8A). In contrast, the presence of
adioactive proteins in samples from IPTG-induced VT7/
P5-infected cells was detected as early as 8 h p.i. At
4 h p.i., the amount of acid-insoluble radioactivity found
n samples from VP5-expressing cultures was approxi-
ately ninefold higher than that in control cell samples
Fig. 8A). The medium samples were also analyzed by
BSC-1 cells were infected with VT7/VP5 and maintained in medium
were fixed, permeabilized or not with Triton X-100, and immunostained
it Ig. Thereafter samples were incubated with TXRD-conjugated WGA.f VP5.
i. cellsDS–PAGE followed by autoradiography. As expected,
edium collected from IPTG-induced VT7/VP5-infected
i
t
a
t ed and
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352 LOMBARDO ET AL.cells contained proteins normally found as cell-associ-
ated polypeptides (data not shown).
We have documented that the presence of BFA blocks
the accumulation of VP5 in the plasma membrane and
prevents the induction of cell death. It was therefore
FIG. 6. Cell viability assays for VP5-expressing cells. (A) BSC-1 cultur
nfection cultures were supplemented with IPTG. The percentage of vi
he cells. (B) BSC-1 cells were infected with VT7LacOI, VT7/VP3, or VT7
ssessed on the basis of mitochondrial activity (MTT assay). (C) BSC-1
he presence or absence of IPTG. At 18 h p.i. coverslips were collect
oupled to TXRD. Thereafter, coverslips were stained with the In Situimportant to assess the effect of BFA on the alteration of
cell membrane permeability. Monolayers of BSC-1 cellswere labeled with [35S]methionine, infected with VT7/
VP5, induced with IPTG, and maintained either in the
presence or in the absence of BFA. As shown in Fig. 8B,
BFA treatment causes an inhibition of approximately 80%
of the release of radioactive polypeptides to the extra-
e mock-infected or infected with VT7LacOI, VT7/VP3, or VT7/VP5. After
lls was determined on the basis of the exclusion of trypan blue from
fter infection, cultures were supplemented with IPTG. The viability was
s grown on coverslips were infected with VT7/VP5 and maintained in
processed for IF with anti-VP5 antisera using a secondary antibody
ath Detection kit to identify nicked nuclear DNA.es wer
able ce
/VP5. A
culturecellular medium.
These results demonstrate that, in addition to the in-
Aa
353EXPRESSION OF INFECTIOUS BURSAL DISEASE VIRUS VP5 INDUCES CELL LYSISduction of cell death, expression of VP5 strongly alters
the plasma membrane permeability. Disrupting the exo-
cytic pathway and thus preventing the accumulation of
VP5 in the plasma membrane efficiently inhibited this
effect.
DISCUSSION
The subcellular distribution of VP5 was studied using
three expression systems: (i) IBDV-infected CEF; (ii) in-
ducible rVV-infected BSC-1 cells; and (iii) pcINEO/VP5-
transfected Cos-1 cells. In all cases, we detected the
presence of VP5 within the Golgi system and the plasma
membrane. The extensive VP5/WGA colocalization, ob-
served in double-staining experiments, and the changes
in VP5 subcellular distribution induced by treatments
with BFA further confirmed these findings, indicating that
VP5 associates with the plasma membrane. Further-
more, the anti-VP5 antiserum used in this study, raised
against the C-terminal VP5 domain, rendered a strong
surface staining in nonpermeabilized cells. Our experi-
mental data are in agreement with the topology predic-
tions obtained with two independent algorithms, TMpred
and TopPred. In light of these results, we propose that
VP5 is a class II membrane protein with an intracellular
N-terminal tail and an extracellular C-terminal region.
A previous report, using an IBDV VP5 knockout mutant,
FIG. 7. BFA inhibits the induction of cell death caused by expression
of VP5. BSC-1 cells were infected with VT7/VP5 and induced with IPTG.
The cultures were treated or not with BFA. At 18 h p.i. coverslips were
collected and processed for IF with anti-VP5 antisera using a second-
ary antibody coupled to TXRD. Thereafter, coverslips were stained with
the In Situ Cell Death Detection kit to identify nicked nuclear DNA.
rrowheads indicate the position of apoptotic VP5-expressing cells.described the relationship between the inactivation of
the VP5 coding sequence and the reduction of the IBDV-
w
rinduced cytopathic effect (Yao et al., 1998). Hence, our
observation that VP5 expression induced a potent cyto-
toxic effect on different cell systems was not unexpected.
The results described in this report demonstrate that, in
the absence of other IBDV-encoded polypeptides, ex-
pression of VP5 induces cell death. Expression of VP5
causes a rapid alteration of the cell morphology accom-
panied by a fast decline in cell viability as measured by
trypan blue dye exclusion and MTT and TUNEL assays.
The observation that the plasma membrane of VP5-ex-
pressing cells is not only permeable to small molecules,
such as trypan blue, but also to macromolecules, such
as lectin and IgG molecules, strongly supports the hy-
pothesis that accumulation of VP5 alters the plasma
membrane. This alteration might trigger cell death. In
agreement with this hypothesis, BFA treatment, which
FIG. 8. Effect of VP5 expression on the integrity of the plasma
membrane. (A) BSC-1 cells were metabolically labeled with [35S]methi-
onine and then infected with VT7/VP5. Cultures were supplemented or
not with IPTG. At the indicated times the cell media from the different
cultures were collected and used to determine the amount of acid-
precipitable radioactivity. (B) BSC-1 monolayers were metabolically
labeled with [35S]methionine, infected with VT7/VP5, induced with IPTG,
nd treated or not with BFA. At the indicated times the cell supernatants
ere collected and used to determine the amount of acid-precipitable
adioactivity.
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354 LOMBARDO ET AL.prevents the accumulation of VP5 in the plasma mem-
brane, efficiently blocked the induction of cell death.
It has been shown that viral proteins involved in cell
lysis modify the permeability of the cell membrane either
by forming pore structures or by increasing the suscep-
tibility of the membrane to phospholipases (Shai, 1995).
Most of these proteins disrupt the intracellular ionic
gradients by increasing the Ca21 concentration. At this
point we cannot speculate about the mechanism(s) re-
sponsible for the alteration of the plasma membrane
induced by VP5. Work to determine the effect of VP5 on
intracellular Ca21 concentration as well as to assess the
ole of different VP5 domains, i.e., the membrane-span-
ing region and the highly basic C-terminus, in its bio-
ogical activity is currently ongoing.
Results obtained with mutants lacking a functional
P5 gene demonstrated that this polypeptide is nones-
ential for virus replication. VP5 inactivation did not affect
he rate of synthesis of other IBDV-encoded polypeptides
Mundt et al., 1997). The comparison of the one-step
rowth curves of wild-type and VP52 mutant viruses
revealed that VP5 inactivation caused a considerable
delay in the production of extracellular infectious virus.
The BFA treatment of IBDV-infected cells apparently
mimicked the effect of the VP5 inactivation, causing a
delay in the production of extracellular virus. These re-
sults completely fit with the hypothesis that accumulation
of VP5 in the PM leads to a progressive alteration of the
plasma membrane that facilitates the release of the virus
progeny. Unfortunately, studies with the VP52 mutants
id not consider the effect of the mutation on the accu-
ulation of intracellular virus. In light of our results it
ould be interesting to examine this aspect.
In this context it would be expected that the progeny of
P52 mutants would remain cell-associated longer than
the wild-type virus. In cell culture, infected cells would
eventually die, thus discharging their contents, including
the virus progeny, to the extracellular milieu. The in vivo
situation would be rather different. A delay in the release
of the virus progeny would provide more time for the
clearance of the infected cells by the phagocyte. Indeed,
this would be a critical factor in reducing the spread of
the virus and, concomitantly, decreasing its pathogenic-
ity.
Information about the IBDV replication cycle is, as yet,
scarce. Very little is known about crucial steps such as
penetration, transcription, replication, assembly, and the
release of the virus progeny. As is the case with other
naked viruses, it is expected that the release of IBDV
might require the alteration of the cell membrane. Avail-
able information is consistent with the hypothesis that
VP5 plays a role in virus release. Further characterization
of the role of VP5 in virus egress would significantly
contribute to the understanding of the molecular biology
of birnaviruses. These studies might provide clues forthe development of new strategies to control the spread
of IBDV.
MATERIALS AND METHODS
Cells, viruses, and antisera
The IBDV Soroa strain, a pathogenic serotype I virus
isolate, was propagated in CEF as previously described
(Lombardo et al., 1999). The serotype I classic subtype
IBDV Sal 1 strain was grown and titrated in BGM70 cells.
Dr. Y. M. Saif (Ohio State University) kindly provided IBDV
Sal 1 strain and BGM70 cells. The rVV VT7/POLY and
VT7/VP3 have been previously described (Ferna´ndez-
Arias et al., 1997, 1998). rVV were propagated and titrated
in African green monkey kidney epithelial BSC-1 cells
(American Type Culture Collection) as described (Earl
and Moss, 1993). Cells were grown in Dulbecco’s mod-
ified Eagle’s medium (DMEM) (Gibco BRL) containing
10% newborn calf serum (NCS) at 37°C in a humidified
5% CO2 incubator.
Sera anti-VP5 was raised against the oligopeptide
TKRHHKRRDLPRKPE, corresponding to residues 130–
45 of the VP5 sequence, coupled to keyhole limpet
emocyanin (KLH, Pierce). The anti-VP4 serum was gen-
rated by immunization with KRFPHNPRDWDRLPYC
oupled to KLH. Oligopeptide synthesis, coupling, and
mmunization were carried out as described (Ferna´ndez-
rias et al., 1998; Harlow and Lane, 1988). Anti-VP1,
VP2/X, and -VP3 sera have been previously described
Lombardo et al., 1999; Sa´nchez and Rodrı´guez, 1999).
Construction of plasmids and recombinant viruses
Genomic IBDV dsRNA segments were isolated from
purified virus as previously described (Sambrook et al.,
1989). A cDNA corresponding to the IBDV ORF A1 was
generated by RT-PCR using IBDV genomic RNA as tem-
plate and the primers 59-CGCGCTATGGTTAGTAGAGAT-
CAGACAAAC and 59-GACTCTGGGCCTGTCACTGC fol-
lowing a previously described protocol (Heine et al.,
1991). The resulting DNA product was subjected to di-
gestion with NdeI. The resulting 551-bp fragment con-
taining the complete VP5 ORF was inserted into the NdeI
site of the pBSK1 vector generating the derivative plas-
mid pBSK/VP5. The nucleotide sequence of the cloned
fragment was analyzed and shown to be correct. There-
after, the VP5 fragment was isolated from pBSK/VP5 by
restriction with NdeI. This fragment was cloned into the
VV insertion/expression vector pVOTE.2 (Ward et al.,
1995) that had been digested with NdeI. The resulting
plasmid, pVOTE/VP5, was purified and used to obtain the
recombinant virus VT7/VP5. For this, BSC-1 cells were
infected with the rVV VT7LacOI (Ward et al., 1995) and
transfected with pVOTE/VP5. Selection and amplification
of VT7/VP5 were carried out as previously described
(Earl and Moss, 1993). Dr. B. Moss (NIH, Bethesda, MD)
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VT7LacOI.
For the construction of pcINeo/VP5, a DNA fragment
containing the VP5 ORF was generated using the prim-
ers 59-GCGCTCTAGATGGTTAGTAGAGATCAGAC and 59-
CGCGGCGGCCGCTCACTCAGGCTTCCTTGGAAGG and
the plasmid pBSK/VP5 as template. The PCR product
was digested with XbaI and NotI and cloned into the
multiple cloning site of the eukaryotic expression vector
pcINeo.
Analysis of protein expression
Cultures of BSC-1 cells were infected with VT7LacOI
or with VT7/VP5 at a multiplicity of infection of 5 PFU/cell
and maintained in the presence or absence of the in-
ducer IPTG (4 mM final concentration). At 10 h p.i., cells
were washed twice with methionine-free DMEM and
metabolically labeled for 1 h with 100 mCi/ml of [35S]me-
hionine. After being labeled, cells were washed twice
ith PBS and resuspended in sample buffer (62.5 mM
ris–HCl, pH 6.8; 2% SDS; 0.25% bromophenol blue; 5%
lycerol; and 5% b-mercaptoethanol). Protein samples
5–10 mg/sample) were subjected to 15% SDS–PAGE and
then transferred to nitrocellulose filters by electroblot-
ting. Filters were incubated for 16 h at 5°C in blocking
buffer (PBS containing 5% nonfat dry milk). Thereafter,
filters were maintained for 2 h at RT with anti-VP5 anti-
sera diluted in blocking buffer and then incubated for 1 h
at RT with goat anti-rabbit IgG conjugated with horserad-
ish peroxidase (ICN). The membranes were developed in
PBS containing 0.02% 1-chloro-4-naphthol and 0.006%
hydrogen peroxide. After the Western blot results were
recorded, filters were air-dried and subjected to autora-
diography. IBDV infections were carried out on BGM70
cells at an m.o.i. of 5 PFU/cell using the Sal 1 strain. At
18 h p.i. cells were metabolically labeled with 100 mCi/ml
of [35S]methionine. Samples were prepared and analyzed
y SDS–PAGE and Western blotting as described above.
mmunofluorescence
BSC-1 cells were plated on coverslips and infected
ith VT7/VP5 at an m.o.i. of 5 PFU/cell in the presence or
bsence of IPTG. At 16 h p.i. cells were washed twice
ith PBS and fixed with 4% paraformaldehyde for 30 min
t RT. Cells were permeabilized or not with 0.1% Triton
-100 for 10 min at RT. Coverslips were blocked in PBS
ontaining 20% NCS for 20 min and incubated with anti-
P5 diluted 1:100 in PBS containing 5% NCS for 45 min at
7°C followed by incubation with TXRD anti-rabbit IgG
era (Jackson ImmunoResearch Laboratories Inc.). Cov-
rslips were mounted on glass slides and examined by
pifluorescence using a Zeiss Axiophot microscope.
EF cells were infected at an m.o.i. of 5 PFU/cells. At8 h p.i. cells were fixed, permeabilized, incubated with
ntisera against VP1, VPX, VP3, VP4, or VP5, and visual-zed by epifluorescence as described above. Control IF
as carried out using the corresponding preimmune
era. IF Images were captured with a MicroMAX digital
amera (Princeton Instruments Inc.) using the IPLab
pectrum software (Signal Analytics Corp.).
Cos-1 cells grown in coverslips were transfected with
00 ng of plasmid DNA per 106 cells using lipofectamine
(Gibco BRL), following the instructions of the manufac-
turer. To minimize the potential toxic effects arising from
an excess of plasmid DNA or transfecting agents, trans-
fections were performed using suboptimal conditions.
Under these conditions only 10–15% of the cells were
shown to express VP5. At 48 h postransfection cells were
incubated with selected antisera and analyzed by IF as
described above.
MTT assay
BSC-1 cells were infected with the appropriate rVV at
an m.o.i. of 5 PFU/cell (3 3 105 cells/well in a 24-well
ultiwell plate) and maintained in the presence or ab-
ence of IPTG. At different times p.i., MTT (Sigma Chem-
cal Co.) in PBS (0.5 mg/ml) was added to a final volume
f 220 ml/well. Thereafter, cultures were further incu-
bated at 37°C for 1 h. The reaction was stopped by
replacing 150 ml of medium by an equal volume of lysis
buffer (10% Triton X-100, 0.5% isopropanol, 0.5% HCl).
After incubating at 37°C for 10 min, plates were read on
a multiscan microplate reader at 540 nm. Determinations
were carried out in triplicate.
Trypan blue exclusion assay
BSC-1 cells were infected in triplicate with the appro-
priate rVV at an m.o.i. of 5 PFU/cell and maintained in the
presence or absence of IPTG. At the corresponding
times p.i., the medium was removed and cells were
trypsinized. The medium and cell fractions were com-
bined and trypan blue (Gibco BRL) added to a final
concentration of 0.02%. After 3 min, the percentage of
colored cells was determined by direct counting under
the microscope (at least 500 cells were counted at each
time point).
35S-release assay
BSC-1 cells were plated at a density of 1 3 105 cells in
4-well multiwell plates and maintained at 37°C and 5%
O2 overnight. Thereafter, cultures were incubated for
h with methionine-free DMEM supplemented with 20
mCi/ml of [35S]methionine. Labeled cultures were
washed three times with DMEM and then infected with
the corresponding rVV at an m.o.i. of 5 PFU/cell. Cultures
were maintained in the presence or absence of IPTG. At
different times p.i., the medium from selected wells was
recovered and spun down to remove cell debris. These
samples were used to determine the amount of acid-
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356 LOMBARDO ET AL.precipitable radioactivity released from the cells as pre-
viously described (Lombardo et al., 1999).
TUNEL assay
BSC-1 or Cos-1 cells grown on coverslips were either
infected or transfected as described above. At 24 h p.i. or
48 posttransfection, respectively, cells were fixed with 4%
paraformaldehyde for 30 min at RT. Coverslips were then
washed twice with PBS and then incubated for 10 min
with PBS containing 100 mM glycine to block reactive
aldehyde groups. After two washes with PBS, cells were
permeabilized by incubation with 0.1% Triton X-100 sup-
plemented with 0.1% sodium citrate for 10 min at RT.
Coverslips were washed twice with PBS and subjected
to RNase A treatment (10 mg/ml in 10 mM Tris, pH 8.0; 1
mM EDTA) for 1 h at 37°C. Thereafter, coverslips were
processed for IF with anti-VP5 antisera as described
above. Subsequently, cells were stained using the In Situ
Cell Death Detection (TUNEL) Kit (Boehringer Mann-
heim) following the instructions of the manufacturer. Cov-
erslips were examined by epifluorescence using the
FITC or the TXRD filters to detect the TUNEL and the VP5
signals, respectively. Images were captured and pro-
cessed as described above.
Primary sequence analysis
The topological analysis of VP5 was carried out using
the TMpred and TopPred 2 programs. TMpred makes a
prediction of membrane-spanning regions and their ori-
entation. The algorithm is based on the statistical anal-
ysis of TMbase, a database of naturally occurring trans-
membrane proteins. The prediction is made using a
combination of several weight matrices for scoring (Hof-
mann and Stoffel, 1993). TopPred 2 predicts the topology
membrane proteins on the basis of hydrophobicity anal-
ysis, automatic generation of a set of possible topolo-
gies, and ranking of these according to the positive-
inside rule (Von Heine, 1992).
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